Bausch Health Companies Inc. Intangible Assets, Net (Excluding Goodwill)
Bausch Health Companies Inc. (BHC) had Intangible Assets, Net (Excluding Goodwill) of $4.18 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-07-30
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $4.18B.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $4.40B.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $4.64B.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $4.83B.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $4.18B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $4.40B 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $4.64B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $4.83B 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $5.05B 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $5.30B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $5.55B 10-K · filed 2026-02-19 | |
| 2024-09-30 | $5.65B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $5.90B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $6.18B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $6.46B 10-K · filed 2025-02-20 | |
| 2023-09-30 | $6.73B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $5.30B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $5.55B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $5.80B 10-K · filed 2024-02-22 | |
| 2022-09-30 | $6.02B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $6.32B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $6.63B 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $6.95B 10-K · filed 2023-02-23 | |
| 2021-09-30 | $7.26B 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $7.62B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $8.00B 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $8.45B 8-K · filed 2022-05-11 | |
| 2020-09-30 | $8.92B 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $9.30B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $9.73B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $10.20B 8-K · filed 2021-05-04 | |
| 2019-09-30 | $10.65B 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $11.20B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $11.68B 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $12.00B 10-K · filed 2020-02-19 | |
| 2018-09-30 | $12.65B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $13.39B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $14.46B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $15.21B 10-K · filed 2019-02-20 | |
| 2017-09-30 | $16.02B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $17.52B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $18.19B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $18.88B 8-K · filed 2018-08-10 | |
| 2016-09-30 | $20.51B 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $21.34B 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $22.35B 10-Q · filed 2016-06-07 | |
| 2015-12-31 | $23.08B 10-K · filed 2017-03-01 | |
| 2015-09-30 | $22.38B 10-Q · filed 2015-10-26 | |
| 2015-06-30 | $23.15B 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $11.55B 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $11.28B 10-K · filed 2016-04-29 | $11.26B 10-K · filed 2015-02-25 |
| 2014-09-30 | $11.62B 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $11.75B 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $12.70B 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $12.85B 10-K · filed 2015-02-25 | $12.85B 10-K · filed 2014-02-28 |
| 2013-09-30 | $13.09B 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $9.29B 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $9.23B 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $9.31B 10-K · filed 2014-02-28 | |
| 2012-09-30 | $8.04B 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $8.12B 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $7.81B 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $7.64B 10-K · filed 2013-02-28 | $7.66B 10-K · filed 2012-02-29 |
| 2011-09-30 | $6.83B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $6.96B 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $6.56B 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $6.37B 10-K · filed 2012-02-29 | |
| 2010-09-30 | $6.47B 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $1.26B 10-Q · filed 2010-08-06 | |
| 2009-12-31 | $1.34B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |